Faculty profile

Roderick Slavcev

ResearcherPharmacy, School ofUniversity of Waterloo

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Waterloo directory, so their courses may be missing. Find their university profile.

Roderick Slavcev

Researcher

Pharmacy, School of

University of Waterloo

Waterloo, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 3 research grants (3 NSERC), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Latest papers

A novel miniaturized filamentous phagemid as a gene delivery vehicle to target mammalian cells.
Molecular therapy. Nucleic acids · 2025 · senior author
The effects of amyloid beta aggregation on neuronal transcription.
IBRO neuroscience reports · 2023
EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.
Frontiers in immunology · 2022

All 15 publications

Latest funding

A pipeline approach for the rational design of neuronal lineage conversion approaches to treat neurological disorders
SSHRC · 2022 · Co-investigator
$8,000,000
Process Optimization of a DNA Minivector Production System
NSERC · 2019 · Principal investigator
$22,000
Construction and Characterization of intelligent Phage-Assembled Gene Expression systems (iPhAGEs).
NSERC · 2018 · Principal investigator
$168,000

All 9 grants and awards

15 publications.

A novel miniaturized filamentous phagemid as a gene delivery vehicle to target mammalian cells.

Wong S, Jimenez S, Pushparajah D, Prakash R, Slavcev R

Molecular therapy. Nucleic acids2025Senior author

DOI: 10.1016/j.omtn.2025.102571 PMID: 40529625

The effects of amyloid beta aggregation on neuronal transcription.

St Jean J, Slavcev R, Rao PN

IBRO neuroscience reports2023

DOI: 10.1016/j.ibneur.2023.03.009 PMID: 37092125

EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.

Huh H, Chen DW, Foldvari M, Slavcev R, Blay J

Frontiers in immunology2022

DOI: 10.3389/fimmu.2022.957233 PMID: 36591314

Bacteriophage interactions with mammalian tissue: Therapeutic applications.

Huh H, Wong S, St Jean J, Slavcev R

Advanced drug delivery reviews2019Senior author

DOI: 10.1016/j.addr.2019.01.003 PMID: 30659855

Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice.

Razazan A, Nicastro J, Slavcev R, Barati N, Arab A, Mosaffa F, Jaafari MR, Behravan J

Scientific reports2019

DOI: 10.1038/s41598-018-38371-z PMID: 30778090

The viral approach to breast cancer immunotherapy.

Arab A, Behravan N, Razazn A, Barati N, Mosaffa F, Nicastro J, Slavcev R, Behravan J

Journal of cellular physiology2019

DOI: 10.1002/jcp.27150 PMID: 30146692

Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice.

Barati N, Razazan A, Nicastro J, Slavcev R, Arab A, Mosaffa F, Nikpoor AR, Badiee A, Jaafari MR, Behravan J

Cancer letters2018

DOI: 10.1016/j.canlet.2018.03.030 PMID: 29580807

Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response.

Arab A, Nicastro J, Slavcev R, Razazan A, Barati N, Nikpoor AR, Brojeni AAM, Mosaffa F, Badiee A, Jaafari MR, Behravan J

Immunologic research2018

DOI: 10.1007/s12026-017-8969-0 PMID: 29143917

Specific Systems for Imaging.

Sum CH, Shortall SM, Nicastro JA, Slavcev R

Experientia supplementum (2012)2018Senior author

DOI: 10.1007/978-3-319-78259-1_3 PMID: 30536227

Phage-based Nanomedicines as New Immune Therapeutic Agents for Breast Cancer.

Arab A, Robati RY, Nicastro J, Slavcev R, Behravan J

Current pharmaceutical design2018

DOI: 10.2174/1381612824666180327152117 PMID: 29589543

A pipeline approach for the rational design of neuronal lineage conversion approaches to treat neurological disorders

Co-investigatorSSHRC2022New Frontiers in Research Fund - Transformation

Principal investigators: Schuurmans, Carol

$8,000,000

Process Optimization of a DNA Minivector Production System

Principal investigatorNSERC2019Engage Grants Program

Principal investigators: Slavcev, Roderick

$22,000

Construction and Characterization of intelligent Phage-Assembled Gene Expression systems (iPhAGEs).

Principal investigatorNSERC2018Discovery Grants Program - Individual

Principal investigators: Slavcev, Roderick

$168,000

Process Engineering of Emerging Nano-Medicines (PrEEmiuM)

Co-investigatorNSERC2018Collaborative Research and Training Experience

Principal investigators: De Crescenzo, Gregory GJM

Keywords: constructivist approach; drug development continuum; knowledge co-creation; large-scale production; nano-medicines

$1,650,000

Critical Addition of a Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) Mass Spectrometer for the University of Waterloo Mass Spectrometry Facility

Co-investigatorNSERC2016Research Tools and Instruments

Principal investigators: Gauthier, Mario

$150,000

Upgrade of U of Waterloo's primary confocal microscope with state-of-the-art correlative microscopy for co-applicants in 11 departments

Co-investigatorNSERC2015Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Spafford, David

$144,912

Cell sorter for university facility

Co-investigatorNSERC2014Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Dixon, Brian

$150,000

Investigating the Rex exclusion genes of bacteriophage Lambda

Principal investigatorNSERC2013Discovery Grants Program - Individual

Principal investigators: Slavcev, Roderick

$150,000

Entry-level confocal microscope needed for 38 users in the Faculties of Science and Engineering at the University of Waterloo

Co-investigatorNSERC2012Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Spafford, David

$120,464

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Roderick Slavcev

Latest papers

Latest funding

A novel miniaturized filamentous phagemid as a gene delivery vehicle to target mammalian cells.

The effects of amyloid beta aggregation on neuronal transcription.

EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.

Bacteriophage interactions with mammalian tissue: Therapeutic applications.

Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice.

The viral approach to breast cancer immunotherapy.

Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice.

Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response.

Specific Systems for Imaging.

Phage-based Nanomedicines as New Immune Therapeutic Agents for Breast Cancer.

A pipeline approach for the rational design of neuronal lineage conversion approaches to treat neurological disorders

Process Optimization of a DNA Minivector Production System

Construction and Characterization of intelligent Phage-Assembled Gene Expression systems (iPhAGEs).

Process Engineering of Emerging Nano-Medicines (PrEEmiuM)

Critical Addition of a Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) Mass Spectrometer for the University of Waterloo Mass Spectrometry Facility

Upgrade of U of Waterloo's primary confocal microscope with state-of-the-art correlative microscopy for co-applicants in 11 departments

Cell sorter for university facility

Investigating the Rex exclusion genes of bacteriophage Lambda

Entry-level confocal microscope needed for 38 users in the Faculties of Science and Engineering at the University of Waterloo

Frequent collaborators

Marianna Foldvari

Roderick Slavcev

Latest papers

Latest funding

A novel miniaturized filamentous phagemid as a gene delivery vehicle to target mammalian cells.

The effects of amyloid beta aggregation on neuronal transcription.

EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.

Bacteriophage interactions with mammalian tissue: Therapeutic applications.

Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice.

The viral approach to breast cancer immunotherapy.

Immunogenicity and antitumor activity of the superlytic &#x3bb;F7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice.

Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response.

Specific Systems for Imaging.

Phage-based Nanomedicines as New Immune Therapeutic Agents for Breast Cancer.

A pipeline approach for the rational design of neuronal lineage conversion approaches to treat neurological disorders

Process Optimization of a DNA Minivector Production System

Construction and Characterization of intelligent Phage-Assembled Gene Expression systems (iPhAGEs).

Process Engineering of Emerging Nano-Medicines (PrEEmiuM)

Critical Addition of a Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) Mass Spectrometer for the University of Waterloo Mass Spectrometry Facility

Upgrade of U of Waterloo's primary confocal microscope with state-of-the-art correlative microscopy for co-applicants in 11 departments

Cell sorter for university facility

Investigating the Rex exclusion genes of bacteriophage Lambda

Entry-level confocal microscope needed for 38 users in the Faculties of Science and Engineering at the University of Waterloo

Frequent collaborators

Marianna Foldvari

Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice.